242 results
Page 4 of 13
S-3ASR
azgtyd9jv53
4 Mar 21
Automatic shelf registration
12:00am
8-K
EX-99.2
nfc3i qgiv
2 Mar 21
TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results
7:00am
8-K
EX-99.1
jemqp5w rkxqc
2 Mar 21
TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results
7:00am
424B2
erq1 38i1f
16 Feb 21
Prospectus for primary offering
6:17am
424B5
t7fjit laf9
10 Feb 21
Prospectus supplement for primary offering
5:11pm
8-K
EX-99.1
8hh22mn u846tkok3
13 Jan 21
Entry into a Material Definitive Agreement
8:50am
424B5
i386t ntfd6q
27 Nov 20
Prospectus supplement for primary offering
4:46pm
8-K
EX-10.3
yqu2h2db6pw545jb
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-10.2
oufq93xap1jsgxeco
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-10.1
gpgkvgdt1 pzmmf54ko5
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
424B2
v3a 4ew4gskd8fhk
12 Nov 20
Prospectus for primary offering
5:18pm
424B5
h5lbz2zlp2f3 ev
9 Nov 20
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
8fkywmv
9 Nov 20
TherapeuticsMD® Announces Third Quarter 2020 Financial Results
6:55am